Arthur P. Bollon

Chief Executive Officer at Vitruvian BioMedical, Inc.

81 year

Health Technology

Commercial Services

Consumer Services

Arthur P. Bollon active positions

Companies	Position	Start	End
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Director/Board Member	2008-05-27	-
	Independent Dir/Board Member	2008-05-27	-
Vitruvian BioMedical, Inc. Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX.	Chief Executive Officer	2010-12-31	-
	Chairman	2010-12-31	-
	Founder	2010-12-31	-

Career history of Arthur P. Bollon

Former positions of Arthur P. Bollon

Companies	Position	Start	End
Hemobiotech, Inc. Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX.	Chief Executive Officer	2003-09-30	2010-07-31
	Chairman	2003-09-30	2009-10-28
	President	2003-09-30	2010-07-31
Cytoclonal Pharmaceutics, Inc.	Chief Executive Officer	1991-12-31	1999-12-31
	Chairman	1999-12-31	1999-12-31
	Founder	1991-12-31	1999-12-31
	President	-	1999-12-31
Wadley Biosciences, Inc.	Chief Executive Officer	1986-12-31	1990-12-31
	Chairman	1990-12-31	1990-12-31
	Founder	1990-12-31	1990-12-31
	President	-	1990-12-31
IMMUNOTECH LABORATORIES, INC.	Director/Board Member	2009-12-17	-
Biogress LLC	Founder	2009-12-20	-
Biogress LLC	Corporate Officer/Principal	2002-12-31	2009-12-20

Training of Arthur P. Bollon

The Waksman Institute of Microbiology

Doctorate Degree

Statistics

International

United States

Operational

Chief Executive Officer	4
Chairman	4
Founder	4

Sectoral

Health Technology	4
Commercial Services	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	1
IMMUNOTECH LABORATORIES, INC.	Health Technology

Private companies	6
Hemobiotech, Inc. Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX.	Health Technology
Biogress LLC
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Commercial Services
Cytoclonal Pharmaceutics, Inc.	Health Technology
Wadley Biosciences, Inc.
Vitruvian BioMedical, Inc. Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX.	Commercial Services

See company connections